Empowered Funds, LLC Clovis Oncology, Inc. Transaction History

Empowered Funds, LLC

  • $5.56 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Oct 31, 2017
SELL
$67.17 - $84.81 $816,317 - $1.03 Million
-12,153 Closed
0 $0
Q2 2017

Jul 09, 2018
BUY
N/A
12,153 New
12,153 $1.14 Million
Q2 2017

Aug 08, 2017
SELL
N/A
-11,612 Closed
0 $0
Q1 2017

Jul 09, 2018
BUY
N/A
11,612
11,612 $739,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email